2[1]Behar S,Boyko V,Reicher-Reiss H,et al.Ten-year survival after acute myocardial infarction:Comparison of patients with and without diabetes.SPRINT Study Group.Secondary Prevention Reinfarction Israeli Nifedipine Trial.Am Heart J,1997,133(3):290-296 被引量：1
3[2]Kannel W,McGee D.Diabetes and cardiovascular disease:The Framingham study.JAMA,1979,241(19):2035-2038 被引量：1
4[3]Davies M,Bland J.Hangartner J,et al.Factors influencing the presence or absence of acute coronary artery thrombosis.Eur Heart J,1989,10(3):203-208 被引量：1
5[4]Niskanen L,Uusitupa M,Sarlund H,et al.Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2(non-insulin dependent) diabetic patients.Diabetologia,1990,33(4):237-243 被引量：1
6[5]Jensen T,Borch-Johnsen K,Kofoed-Enevoldsen A,et al.Coronary heart disease in young type 1(insulin-dependent)diabetic patients with and without diabetic nephrop-athy:Incidence and risk factors.Diabetologia,1987,30(3):144-148 被引量：1
7[6]Margolis J,Kannel W,Feinlieb M,et al.Clinical features of unrecognized myocardial infarction-silent and symptomatic.Am J Cardiol,1973,32(1):1-7 被引量：1
9[8]Harpaz D,Gottlieb S,Graft E,et al.Effects of aspirin treatment on survival in noninsulin-dependent diabetic patients with coronary artery disease:Isreali Bezafibrate Infarction Prevention Study Group.Am J Med,1998,105(6):494-499 被引量：1
10[9]Indications for fibrinolytic therapy in suspected acute myocaridial infarction:Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients.Fibrinolytic Therapy Trialists'(FTT) Collaborative Group[published erratum appears in Lancet 1994 Mar19,343(8899):742] [See comments].Lancet,1994,343(8893):311-322 被引量：1
